Embryonic Genetic Testing PGT for HRC
HRC's Drs. Kolb, Potter, and Wilcox's profiles are all involved in clinical and research work related to embryonic genetic screening or testing. The project involves the interface between clinical, embryonic laboratory and genetic testing.
PGT is the genetic testing of embryo samples before embryo transfer. The sample is usually from an embryo biopsy and the test report is used to discuss embryo transfer options.
| link | Content |
|---|---|
| PGT-A | Screening for abnormal chromosome numbers. |
| PGT-M | Targeting specific known single-gene genetic diseases. |
| PGT-SR | Aiming at problems related to chromosome structural rearrangement. |
| Biopsy and Testing | Embryo biopsy and sample testing are different steps and may be completed by different laboratories. |
| Report explanation | Results such as no results, abnormality or mosaicism require explanation by doctors and genetic counselors. |
Biopsy, detection and reporting are implemented separately
- Who performs the biopsy, where is the sample sent, and who issues and interprets the report?
- Do existing genetic reports or family history require further evaluation?
- How to discuss subsequent options when there are no results, chimerism, or other complex results?
- Are biopsy, external testing, genetic counseling, freezing and preservation billed separately?
Testing does not guarantee implantation, pregnancy, or live birth, and does not cover all genetic diseases. Prenatal screening or diagnosis should still be discussed with your health care team after pregnancy.
Associate doctors and laboratories
The personal information of Doctors Kolb and Potter introduced in this section involves embryonic genetic screening or testing-related backgrounds. Understanding the background does not equate to determining admissions, testing options, or embryos for transfer.